Dr Rachel Melsom on why engagement with the tobacco industry may be futile, due to its negative health and social repercussions.
Dr Rachel Melsom on why engagement with the tobacco industry may be futile, due to its negative health and social repercussions.
March 2018
Dr Rachel Melsom describes why investor engagement with the tobacco industry, relative for instance to the fossil fuel industry, is futile because of its negative health and social repercussions. She also explains why international policy momentum – the WHO Tobacco Convention, the UN Global Compact Statement and the UN’s Sustainable Development Goals – provide a framework to understand the broader socio-economic implications of tobacco, and the momentum behind recent investor announcements to go tobacco-free.
Recording date: 14 Dec 2017
Dr Rachel Melsom
Dr Rachel Melsom is Director of Tobacco Free Portfolios for the UK and Europe, and a practicing Doctor. Tobacco Free Portfolios focuses on the medical and societal cost of continued investment in the Tobacco Industry, addressing the effect of the product and the wider cost of smoking to society, encouraging Tobacco Free Investment. Rachel also works part time in the Department of Medicine for the Elderly (DoME) at Worthing Hospital in Sussex.
You are now exiting our website
Please be aware that you are now exiting the Man Institute | Man Group website. Links to our social media pages are provided only as a reference and courtesy to our users. Man Institute | Man Group has no control over such pages, does not recommend or endorse any opinions or non-Man Institute | Man Group related information or content of such sites and makes no warranties as to their content. Man Institute | Man Group assumes no liability for non Man Institute | Man Group related information contained in social media pages. Please note that the social media sites may have different terms of use, privacy and/or security policy from Man Institute | Man Group.